Variant report

Variant	nsv1031279
Chromosome Location	chr8:10448142-10501380
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:36)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:1)

No data

(count:36 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr8:10451891..10453978-chr8:10460350..10462448,2	K562	blood:
2	chr8:10471165..10472668-chr8:10474766..10476740,2	K562	blood:
3	chr8:10483888..10486004-chr8:10489138..10491581,2	K562	blood:
4	chr8:10466383..10469729-chr8:10471205..10473307,3	K562	blood:
5	chr8:10483888..10486004-chr8:10489138..10491581,2	K562	blood:
6	chr8:10450511..10453354-chr8:10693058..10695560,2	K562	blood:
7	chr8:10461544..10463468-chr8:10674781..10677553,2	K562	blood:
8	chr8:10483740..10486266-chr8:10497688..10499815,2	MCF-7	breast:
9	chr8:10494258..10496220-chr8:10499255..10501363,2	K562	blood:
10	chr8:10498586..10501129-chr8:10504266..10507624,3	K562	blood:
11	chr8:10464134..10466751-chr8:10479070..10481412,2	K562	blood:
12	chr8:10447404..10448576-chr8:10655982..10656998,11	MCF-7	breast:
13	chr8:10447773..10448295-chr8:10656037..10656649,2	MCF-7	breast:
14	chr8:10464134..10466751-chr8:10479070..10481412,2	K562	blood:
15	chr8:10451891..10453978-chr8:10460350..10462448,2	K562	blood:
16	chr8:10443749..10446739-chr8:10451129..10452843,2	K562	blood:
17	chr8:10481194..10482903-chr8:10484662..10486783,2	K562	blood:
18	chr8:10447015..10448532-chr8:10696136..10697603,15	K562	blood:
19	chr8:10446054..10448904-chr8:10503289..10505926,2	K562	blood:
20	chr8:10447388..10448227-chr8:10671479..10672292,5	MCF-7	breast:
21	chr8:10483740..10486266-chr8:10497688..10499815,2	MCF-7	breast:
22	chr8:10471165..10472668-chr8:10474766..10476740,2	K562	blood:
23	chr8:10447286..10448405-chr8:10682073..10684028,19	K562	blood:
24	chr8:10447720..10448261-chr8:10675847..10676686,2	K562	blood:
25	chr8:10447282..10448390-chr8:10682147..10683493,10	MCF-7	breast:
26	chr8:10447691..10448293-chr8:10586014..10586821,3	MCF-7	breast:
27	chr8:10494258..10496220-chr8:10499255..10501363,2	K562	blood:
28	chr8:10481194..10482903-chr8:10484662..10486783,2	K562	blood:
29	chr8:10447712..10448262-chr8:10591419..10591945,2	MCF-7	breast:
30	chr8:10447717..10449945-chr8:10695392..10697388,2	MCF-7	breast:
31	chr17:57915711..57917705-chr8:10466490..10468325,2	MCF-7	breast:
32	chr8:10448565..10449854-chr8:10682554..10683407,5	K562	blood:
33	chr8:10447312..10448291-chr8:10671241..10672318,3	MCF-7	breast:
34	chr8:10447726..10448226-chr8:10680360..10680981,2	K562	blood:
35	chr8:10466383..10469729-chr8:10471205..10473307,3	K562	blood:
36	chr8:10450308..10452176-chr8:10695894..10698184,2	MCF-7	breast:

No data

(count:1 , 50 per page) page: 1

No.	miRNA target gene	miRNA name	Chromosome Location	mirBase accession
1	RP1L1	hsa-miR-335-5p	chr8:10464033-10464056

Variant related genes	Relation type
ENSG00000254093	chromatin interactions
ENSG00000253695	chromatin interactions
ENSG00000258724	chromatin interactions

Extended variants
information (count: 3755 )
Associated
traits (count: 138 )

Variant overlapped rSNPs/rCNVs (count:3755 , 50 per page) page: 1 2 3 4 5 6 7 ... 76

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs12681639	chr8:10448142-10448143	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs188758076	chr8:10448153-10448154	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs181145738	chr8:10448168-10448169	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs550768687	chr8:10448204-10448205	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs184385157	chr8:10448209-10448210	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs576711768	chr8:10448217-10448218	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs540650837	chr8:10448277-10448278	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs541410381	chr8:10448298-10448299	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs4841388	chr8:10448328-10448329	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs532847893	chr8:10448329-10448330	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs552864892	chr8:10448330-10448331	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs563181017	chr8:10448333-10448334	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs137884764	chr8:10448361-10448362	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs149450733	chr8:10448382-10448383	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs568447112	chr8:10448384-10448385	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs569080012	chr8:10448445-10448446	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs534329768	chr8:10448479-10448480	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs547472045	chr8:10448483-10448484	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs34705338	chr8:10448517-10448518	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs570551481	chr8:10448518-10448519	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs115961932	chr8:10448537-10448538	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs145945153	chr8:10448543-10448544	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs561474165	chr8:10448557-10448558	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs138562128	chr8:10448589-10448590	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs535259490	chr8:10448600-10448601	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs530628391	chr8:10448652-10448653	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs555568861	chr8:10448664-10448665	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs572021993	chr8:10448675-10448676	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs541164269	chr8:10448682-10448683	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs28634925	chr8:10448694-10448695	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs370242390	chr8:10448696-10448697	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs373639998	chr8:10448712-10448713	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs143052120	chr8:10448715-10448716	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs372666054	chr8:10448730-10448731	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs543465330	chr8:10448747-10448748	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs563142394	chr8:10448757-10448758	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs189270914	chr8:10448769-10448770	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs180846563	chr8:10448784-10448785	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs79816894	chr8:10448836-10448837	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs527774405	chr8:10448853-10448854	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs546937975	chr8:10448863-10448864	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs566738372	chr8:10448864-10448865	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs186428104	chr8:10448874-10448875	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs570613410	chr8:10448881-10448882	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs539417829	chr8:10448894-10448895	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs113492258	chr8:10448916-10448917	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs539707209	chr8:10448933-10448934	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs141641333	chr8:10448937-10448938	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs371575062	chr8:10448949-10448950	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs555266198	chr8:10448961-10448962	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:138)

Disease	PMID	Source
Crohn''s disease	19220326	CNVD
Psoriasis	19220326	CNVD
Prostate cancer	21965145	CNVD
Prostate cancer	18515986	CNVD
Chronic obstructive pulmonary disease	20378733	CNVD
Autism	18414403	CNVD
Cancer	21183584	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Breast cancer	17603634	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Ovarian cancer	20844748	CNVD
Cervical cancer	17311676	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Schizophrenia	20877625	CNVD
Disorders of sex development	21048976	CNVD
Colorectal cancer	16272173	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Breast cancer	17001317	CNVD
Thyroid cancer	19087340	CNVD
Multiple myeloma	16616336	CNVD
Hepatocellular carcinoma	22174799	CNVD
Heart disease	21282601	CNVD
Prostate cancer	16573809	CNVD
T-cell lymphomas	19863542	CNVD
Ovarian cancer	22174824	CNVD
Colorectal cancer	21297112	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Salivary gland tumor	18059337	CNVD
Breast cancer	17133270	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Breast cancer	17393978	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Breast cancer	20837533	CNVD
Squamous cell cancer	21044232	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	22429812	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Colorectal cancer	20709793	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Basal cell lymphoma	21115979	CNVD
Breast cancer	21264507	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Prostate cancer	21088497	CNVD
Breast cancer	20940404	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Gastric cancer	17167181	CNVD
Prostate cancer	16705090	CNVD
8p-syndrome	17576883	CNVD
Human rectal carcinomas	16397240	CNVD
Medulloblastoma	16968546	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung cancer	19525976	CNVD
Prostate cancer	17245344	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Cancer	16751803	CNVD
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Autism	19415332	CNVD
Malaria	21533027	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Esophageal cancer	21851588	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	21245420	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Breast cancer	21785460	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	21509527	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Acute myeloid leukemia	21251322	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
lymphocytic leukemia	21291569	CNVD
Liver carcinoma	19366792	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Congenital diaphragmatic hernia	21064195	CNVD
Autism	22495311	CNVD
Myelofibrosis	22110671	CNVD
Intellectual disability	22045946	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Breast cancer	16608533	CNVD
Seminomas	18059402	CNVD
Lung cancer	18438408	CNVD
Lung squamous cell carcinoma	22363434	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Breast cancer	21990379	CNVD
Psoriasis	20403174	CNVD
Psoriasis	20663923	CNVD
Crohn''s disease	16909382	CNVD
Cancer	21129771	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Crohn''s disease	20877625	CNVD
Inflammatory disorder	20877625	CNVD
Cardiac defect	21933911	CNVD
Psoriasis	18059266	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Psoriasis	20877625	CNVD
Mental retardation	17847001	CNVD
Prostate cancer	17217626	CNVD
Schizophrenia	21399695	CNVD
Colorectal cancer	21128281	CNVD
Colorectal cancer	19455253	CNVD
Psoriasis	18848619	CNVD
Squamous cell cancer	19047905	CNVD
Colorectal cancer	17229543	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Myxofibrosarcoma	16751306	CNVD
Immune disease	21572526	CNVD
Non-small cell lung cancer	21829676	CNVD
Ovarian neoplasms	16753589	CNVD
Kallmann Syndrome 2	22470819	CNVD
Developmental disorder	20461109	CNVD
abnormal development	18461090	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Glioblastoma multiforme	21138945	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21364760	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Gastric cancer	21811585	CNVD
Colorectal cancer	16774939	CNVD
Osteosarcoma	21215367	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:636 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr8:10439000-10453000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
2	chr8:10445200-10450400	Weak transcription	Brain Inferior Temporal Lobe	brain
3	chr8:10446800-10448200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
4	chr8:10447400-10449200	Enhancers	Lung	lung
5	chr8:10447800-10448200	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
6	chr8:10447800-10448200	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
7	chr8:10447800-10448200	Enhancers	Liver	Liver
8	chr8:10447800-10448200	Bivalent Enhancer	Fetal Stomach	stomach
9	chr8:10447800-10448200	Bivalent Enhancer	Stomach Smooth Muscle	stomach
10	chr8:10447800-10448400	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
11	chr8:10447800-10448600	Enhancers	Adipose Nuclei	Adipose
12	chr8:10447800-10449600	Bivalent Enhancer	Fetal Muscle Leg	muscle
13	chr8:10447800-10449600	Enhancers	HUVEC	blood vessel
14	chr8:10447800-10452000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
15	chr8:10448000-10448200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
16	chr8:10448000-10448200	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
17	chr8:10448000-10448200	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
18	chr8:10448000-10448200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
19	chr8:10448000-10448200	Bivalent Enhancer	Brain Germinal Matrix	brain
20	chr8:10448000-10448200	Flanking Active TSS	Hela-S3	cervix
21	chr8:10448000-10448200	Enhancers	NH-A	brain
22	chr8:10448200-10450200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
23	chr8:10448200-10450800	Weak transcription	Hela-S3	cervix
24	chr8:10448200-10451000	Weak transcription	NH-A	brain
25	chr8:10448200-10451400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
26	chr8:10448200-10456200	Weak transcription	Liver	Liver
27	chr8:10448600-10448800	Bivalent Enhancer	K562	blood
28	chr8:10448600-10449000	Enhancers	Spleen	Spleen
29	chr8:10448600-10449200	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
30	chr8:10448600-10449400	Bivalent Enhancer	Adipose Nuclei	Adipose
31	chr8:10449000-10454600	Weak transcription	Spleen	Spleen
32	chr8:10449600-10453800	Enhancers	Primary neutrophils fromperipheralblood	blood
33	chr8:10449800-10450200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
34	chr8:10449800-10450200	Enhancers	K562	blood
35	chr8:10450000-10450200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
36	chr8:10450000-10450200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
37	chr8:10450000-10450200	Bivalent Enhancer	Fetal Muscle Leg	muscle
38	chr8:10450000-10451400	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
39	chr8:10450000-10452000	Enhancers	Brain Anterior Caudate	brain
40	chr8:10450200-10452000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
41	chr8:10450400-10450600	Enhancers	H1 Cell Line	embryonic stem cell
42	chr8:10450400-10450600	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
43	chr8:10450400-10450600	Enhancers	HUES6 Cell Line	embryonic stem cell
44	chr8:10450400-10450600	Enhancers	Lung	lung
45	chr8:10450400-10450600	Bivalent Enhancer	Stomach Smooth Muscle	stomach
46	chr8:10450400-10451200	Enhancers	Brain Hippocampus Middle	brain
47	chr8:10450400-10451600	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
48	chr8:10450400-10451600	Enhancers	Brain Inferior Temporal Lobe	brain
49	chr8:10450600-10450800	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
50	chr8:10450600-10451200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links